[1]
Shvarts, G.Y. 2005. Pharmacoeconomic assessment of the effectiveness of glatiramer acetate (Copaxone®) in patients with multiple sclerosis. Ukrainian Neurosurgical Journal. 2 (Jun. 2005), 85–91. DOI:https://doi.org/10.25305/unj.132316.